Medical Devices

Global Antiretroviral Therapy Market Insights, Forecast to 2025

  • QYR2789049
  • 111 Pages
  • October 2018
  • Medical Devices
Download Sample    Get Discount   
 
The global Antiretroviral Therapy market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The objectives of this study are to define, segment, and project the size of the Antiretroviral Therapy market based on company, product type, end user and key regions.

This report studies the global market size of Antiretroviral Therapy in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antiretroviral Therapy in these regions.

This research report categorizes the global Antiretroviral Therapy market by top players/brands, region, type and end user. This report also studies the global Antiretroviral Therapy market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

Gilead

F. Hoffmann-La Roche

ViiV Healthcare

Boehringer Ingelheim

Janssen Pharmaceuticals

Mylan

Abbvie

Bionor Pharma

Vertex Pharmaceuticals

Market size by Product

NNRTIs

NRTI

Multiclass Combination Products

Integrase Inhibitors

Market size by End User

Hospital

Clinic

Other

Market size by Region

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Malaysia

Philippines

Thailand

Vietnam

Europe

Germany

France

UK

Italy

Spain

Russia

Central & South America

Brazil

Rest of Central & South America

Middle East & Africa

GCC Countries

Turkey

Egypt

South Africa

The study objectives of this report are:

To study and analyze the global Antiretroviral Therapy market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.

To understand the structure of Antiretroviral Therapy market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Antiretroviral Therapy companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

To project the value and sales volume of Antiretroviral Therapy submarkets, with respect to key regions.

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Antiretroviral Therapy are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Antiretroviral Therapy market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage

1.1 Antiretroviral Therapy Product

1.2 Market Segments

1.3 Key Manufacturers Covered

1.4 Market by Type

1.4.1 Global Antiretroviral Therapy Market Size Growth Rate by Product

1.4.2 NNRTIs

1.4.3 NRTI

1.4.4 Multiclass Combination Products

1.4.5 Integrase Inhibitors

1.5 Market by End User

1.5.1 Global Antiretroviral Therapy Market Size Growth Rate by End User

1.5.2 Hospital

1.5.3 Clinic

1.5.4 Other

1.6 Study Objectives

1.7 Years Considered

2 Executive Summary

2.1 Global Antiretroviral Therapy Market Size

2.1.1 Global Antiretroviral Therapy Revenue 2013-2025

2.1.2 Global Antiretroviral Therapy Sales 2013-2025

2.2 Antiretroviral Therapy Growth Rate by Regions

2.2.1 Global Antiretroviral Therapy Sales by Regions

2.2.2 Global Antiretroviral Therapy Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Antiretroviral Therapy Sales by Manufacturers

3.1.1 Antiretroviral Therapy Sales by Manufacturers

3.1.2 Antiretroviral Therapy Sales Market Share by Manufacturers

3.1.3 Global Antiretroviral Therapy Market Concentration Ratio (CR5 and HHI)

3.2 Antiretroviral Therapy Revenue by Manufacturers

3.2.1 Antiretroviral Therapy Revenue by Manufacturers (2013-2018)

3.2.2 Antiretroviral Therapy Revenue Share by Manufacturers (2013-2018)

3.3 Antiretroviral Therapy Price by Manufacturers

3.4 Antiretroviral Therapy Manufacturing Base Distribution, Product Types

3.4.1 Antiretroviral Therapy Manufacturers Manufacturing Base Distribution, Headquarters

3.4.2 Manufacturers Antiretroviral Therapy Product Type

3.4.3 Date of International Manufacturers Enter into Antiretroviral Therapy Market

3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

4.1 Global Antiretroviral Therapy Sales by Product

4.2 Global Antiretroviral Therapy Revenue by Product

4.3 Antiretroviral Therapy Price by Product

5 Breakdown Data by End User

5.1 Overview

5.2 Global Antiretroviral Therapy Breakdown Data by End User

6 North America

6.1 North America Antiretroviral Therapy by Countries

6.1.1 North America Antiretroviral Therapy Sales by Countries

6.1.2 North America Antiretroviral Therapy Revenue by Countries

6.1.3 United States

6.1.4 Canada

6.1.5 Mexico

6.2 North America Antiretroviral Therapy by Product

6.3 North America Antiretroviral Therapy by End User

7 Europe

7.1 Europe Antiretroviral Therapy by Countries

7.1.1 Europe Antiretroviral Therapy Sales by Countries

7.1.2 Europe Antiretroviral Therapy Revenue by Countries

7.1.3 Germany

7.1.4 France

7.1.5 UK

7.1.6 Italy

7.1.7 Russia

7.2 Europe Antiretroviral Therapy by Product

7.3 Europe Antiretroviral Therapy by End User

8 Asia Pacific

8.1 Asia Pacific Antiretroviral Therapy by Countries

8.1.1 Asia Pacific Antiretroviral Therapy Sales by Countries

8.1.2 Asia Pacific Antiretroviral Therapy Revenue by Countries

8.1.3 China

8.1.4 Japan

8.1.5 Korea

8.1.6 India

8.1.7 Australia

8.1.8 Indonesia

8.1.9 Malaysia

8.1.10 Philippines

8.1.11 Thailand

8.1.12 Vietnam

8.1.13 Singapore

8.2 Asia Pacific Antiretroviral Therapy by Product

8.3 Asia Pacific Antiretroviral Therapy by End User

9 Central & South America

9.1 Central & South America Antiretroviral Therapy by Countries

9.1.1 Central & South America Antiretroviral Therapy Sales by Countries

9.1.2 Central & South America Antiretroviral Therapy Revenue by Countries

9.1.3 Brazil

9.2 Central & South America Antiretroviral Therapy by Product

9.3 Central & South America Antiretroviral Therapy by End User

10 Middle East and Africa

10.1 Middle East and Africa Antiretroviral Therapy by Countries

10.1.1 Middle East and Africa Antiretroviral Therapy Sales by Countries

10.1.2 Middle East and Africa Antiretroviral Therapy Revenue by Countries

10.1.3 GCC Countries

10.1.4 Turkey

10.1.5 Egypt

10.1.6 South Africa

10.2 Middle East and Africa Antiretroviral Therapy by Product

10.3 Middle East and Africa Antiretroviral Therapy by End User

11 Company Profiles

11.1 Gilead

11.1.1 Gilead Company Details

11.1.2 Company Business Overview

11.1.3 Gilead Antiretroviral Therapy Sales, Revenue and Gross Margin (2013-2018)

11.1.4 Gilead Antiretroviral Therapy Products Offered

11.1.5 Gilead Recent Development

11.2 F. Hoffmann-La Roche

11.2.1 F. Hoffmann-La Roche Company Details

11.2.2 Company Business Overview

11.2.3 F. Hoffmann-La Roche Antiretroviral Therapy Sales, Revenue and Gross Margin (2013-2018)

11.2.4 F. Hoffmann-La Roche Antiretroviral Therapy Products Offered

11.2.5 F. Hoffmann-La Roche Recent Development

11.3 ViiV Healthcare

11.3.1 ViiV Healthcare Company Details

11.3.2 Company Business Overview

11.3.ViiV Healthcare Antiretroviral Therapy Sales, Revenue and Gross Margin (2013-2018)

11.3.4 ViiV Healthcare Antiretroviral Therapy Products Offered

11.3.5 ViiV Healthcare Recent Development

11.4 Boehringer Ingelheim

11.4.1 Boehringer Ingelheim Company Details

11.4.2 Company Business Overview

11.4.3 Boehringer Ingelheim Antiretroviral Therapy Sales, Revenue and Gross Margin (2013-2018)

11.4.4 Boehringer Ingelheim Antiretroviral Therapy Products Offered

11.4.5 Boehringer Ingelheim Recent Development

11.5 Janssen Pharmaceuticals

11.5.1 Janssen Pharmaceuticals Company Details

11.5.2 Company Business Overview

11.5.3 Janssen Pharmaceuticals Antiretroviral Therapy Sales, Revenue and Gross Margin (2013-2018)

11.5.4 Janssen Pharmaceuticals Antiretroviral Therapy Products Offered

11.5.5 Janssen Pharmaceuticals Recent Development

11.6 Mylan

11.6.1 Mylan Company Details

11.6.2 Company Business Overview

11.6.3 Mylan Antiretroviral Therapy Sales, Revenue and Gross Margin (2013-2018)

11.6.4 Mylan Antiretroviral Therapy Products Offered

11.6.5 Mylan Recent Development

11.7 Abbvie

11.7.1 Abbvie Company Details

11.7.2 Company Business Overview

11.7.3 Abbvie Antiretroviral Therapy Sales, Revenue and Gross Margin (2013-2018)

11.7.4 Abbvie Antiretroviral Therapy Products Offered

11.7.5 Abbvie Recent Development

11.8 Bionor Pharma

11.8.1 Bionor Pharma Company Details

11.8.2 Company Business Overview

11.8.3 Bionor Pharma Antiretroviral Therapy Sales, Revenue and Gross Margin (2013-2018)

11.8.4 Bionor Pharma Antiretroviral Therapy Products Offered

11.8.5 Bionor Pharma Recent Development

11.9 Vertex Pharmaceuticals

11.9.1 Vertex Pharmaceuticals Company Details

11.9.2 Company Business Overview

11.9.3 Vertex Pharmaceuticals Antiretroviral Therapy Sales, Revenue and Gross Margin (2013-2018)

11.9.4 Vertex Pharmaceuticals Antiretroviral Therapy Products Offered

11.9.5 Vertex Pharmaceuticals Recent Development

12 Future Forecast

12.1 Antiretroviral Therapy Market Forecast by Regions

12.1.1 Global Antiretroviral Therapy Sales Forecast by Regions 2018-2025

12.1.2 Global Antiretroviral Therapy Revenue Forecast by Regions 2018-2025

12.2 Antiretroviral Therapy Market Forecast by Product

12.2.1 Global Antiretroviral Therapy Sales Forecast by Product 2018-2025

12.2.2 Global Antiretroviral Therapy Revenue Forecast by Product 2018-2025

12.3 Antiretroviral Therapy Market Forecast by End User

12.4 North America Antiretroviral Therapy Forecast

12.5 Europe Antiretroviral Therapy Forecast

12.6 Asia Pacific Antiretroviral Therapy Forecast

12.7 Central & South America Antiretroviral Therapy Forecast

12.8 Middle East and Africa Antiretroviral Therapy Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers

13.2 Market Challenges

13.3 Market Risks/Restraints

13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis

14.2 Antiretroviral Therapy Customers

14.3 Sales Channels Analysis

14.3.1 Sales Channels

14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.2 Data Source

16.2 Author Details

16.3 Disclaimer

List of Tables and Figures

Figure Antiretroviral Therapy Product Picture

Table Antiretroviral Therapy Market Segments

Table Key Manufacturers Antiretroviral Therapy Covered

Table Global Antiretroviral Therapy Market Size Growth Rate by Product 2018-2025 (K Units) & (Million US$)

Figure Global Antiretroviral Therapy Sales Market Share by Product 2013-2025

Figure NNRTIs Product Picture

Table Major Manufacturers of NNRTIs

Figure NRTI Product Picture

Table Major Manufacturers of NRTI

Figure Multiclass Combination Products Product Picture

Table Major Manufacturers of Multiclass Combination Products

Figure Integrase Inhibitors Product Picture

Table Major Manufacturers of Integrase Inhibitors

Table Global Antiretroviral Therapy Market Size Growth Rate by End User 2018-2025 (K Units)

Figure Hospital

Figure Clinic

Figure Other

Figure Antiretroviral Therapy Report Years Considered

Figure Global Antiretroviral Therapy Market Size 2013-2025 (Million US$)

Figure Global Antiretroviral Therapy Sales 2013-2025 (K Units)

Table Global Antiretroviral Therapy Market Size by Regions 2013-2018 (K Units) & (Million US$)

Table Global Antiretroviral Therapy Sales by Regions 2013-2018 (K Units)

Table Global Antiretroviral Therapy Sales Market Share by Regions 2013-2018

Figure Global Antiretroviral Therapy Sales Market Share by Regions 2013-2018

Figure 2017 Global Antiretroviral Therapy Sales Market Share by Regions

Table Global Antiretroviral Therapy Revenue by Regions 2013-2018 (Million US$)

Table Global Antiretroviral Therapy Revenue Market Share by Regions 2013-2018

Figure Global Antiretroviral Therapy Revenue Market Share by Regions 2013-2018

Figure 2017 Global Antiretroviral Therapy Revenue Market Share by Regions

Table Global Antiretroviral Therapy Sales by Manufacturers (2013-2018) (K Units)

Table Global Antiretroviral Therapy Sales Share by Manufacturers (2013-2018)

Figure Global Antiretroviral Therapy Sales Share by Manufacturers in 2017

Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table Antiretroviral Therapy Revenue by Manufacturers (2013-2018) (Million USD)

Table Antiretroviral Therapy Revenue Share by Manufacturers (2013-2018)

Figure Antiretroviral Therapy Value Share by Manufacturers in 2017

Table Key Manufacturers Antiretroviral Therapy Price (2013-2018) (USD/Unit)

Table Antiretroviral Therapy Manufacturers Manufacturing Base Distribution and Headquarters

Table Manufacturers Antiretroviral Therapy Product Type

Table Date of International Manufacturers Enter into Antiretroviral Therapy Market

Table Manufacturers Mergers & Acquisitions, Expansion Plans

Table Global Antiretroviral Therapy Sales by Product (2013-2018) (K Units)

Table Global Antiretroviral Therapy Sales Share by Product (2013-2018)

Figure Global Antiretroviral Therapy Sales Market Share by Product (2013-2018)

Figure Global Antiretroviral Therapy Sales Market Share by Product in 2017

Table Global Antiretroviral Therapy Revenue by Product (2013-2018) (Million US$)

Table Global Antiretroviral Therapy Revenue Share by Product (2013-2018)

Figure Global Antiretroviral Therapy Revenue Market Share by Product (2013-2018)

Figure Global Antiretroviral Therapy Revenue Market Share by Product in 2017

Table Antiretroviral Therapy Price by Product 2013-2018 (USD/Unit)

Table Global Antiretroviral Therapy Sales by End User (2013-2018) (K Units)

Table Global Antiretroviral Therapy Sales Share by End User (2013-2018)

Figure Global Sales Antiretroviral Therapy Market Share by End User (2013-2018)

Figure Global Sales Antiretroviral Therapy Market Share by End User in 2017

Figure North America Antiretroviral Therapy Sales Growth Rate 2013-2018 (K Units)

Figure North America Antiretroviral Therapy Revenue Growth Rate 2013-2018 (Million US$)

Table North America Antiretroviral Therapy Sales by Countries (2013-2018) (K Units)

Table North America Antiretroviral Therapy Sales Market Share by Countries (2013-2018)

Figure 2017 North America Antiretroviral Therapy Sales Market Share by Countries

Table North America Antiretroviral Therapy Revenue by Countries (2013-2018) (Million US$)

Table North America Antiretroviral Therapy Revenue Market Share by Countries (2013-2018)

Figure 2017 North America Antiretroviral Therapy Revenue Market Share by Countries

Figure United States Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)

Figure United States Antiretroviral Therapy Revenue Growth Rate (2013-2018) (K Units)

Figure Canada Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)

Figure Canada Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)

Figure Mexico Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)

Figure Mexico Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)

Table North America Antiretroviral Therapy Sales by Product (2013-2018) (K Units)

Table North America Antiretroviral Therapy Sales Market Share by Product (2013-2018)

Figure 2017 North America Antiretroviral Therapy Market Share by Product

Table North America Antiretroviral Therapy Sales by End User (2013-2018) (K Units)

Table North America Antiretroviral Therapy Sales Market Share by End User (2013-2018)

Figure 2017 North America Antiretroviral Therapy Market Share by End User

Figure Europe Antiretroviral Therapy Sales Growth Rate 2013-2018 (K Units)

Figure Europe Antiretroviral Therapy Revenue Growth Rate 2013-2018 (Million US$)

Table Europe Antiretroviral Therapy Sales by Countries (2013-2018) (K Units)

Table Europe Antiretroviral Therapy Sales Market Share by Countries (2013-2018)

Figure 2017 Europe Antiretroviral Therapy Sales Market Share by Countries

Table Europe Antiretroviral Therapy Revenue by Countries (2013-2018) (Million US$)

Table Europe Antiretroviral Therapy Revenue Market Share by Countries (2013-2018)

Figure 2017 Europe Antiretroviral Therapy Revenue Market Share by Countries

Figure Germany Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)

Figure Germany Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)

Figure France Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)

Figure France Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)

Figure UK Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)

Figure UK Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)

Figure Italy Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)

Figure Italy Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)

Figure Russia Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)

Figure Russia Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)

Table Europe Antiretroviral Therapy Sales by Product (2013-2018) (K Units)

Table Europe Antiretroviral Therapy Sales Market Share by Product (2013-2018)

Figure 2017 Europe Antiretroviral Therapy Market Share by Product

Table Europe Antiretroviral Therapy Sales by End User (2013-2018) (K Units)

Table Europe Antiretroviral Therapy Sales Market Share by End User (2013-2018)

Figure 2017 Europe Antiretroviral Therapy Market Share by End User

Figure Asia Pacific Antiretroviral Therapy Sales Growth Rate 2013-2018 (K Units)

Figure Asia Pacific Antiretroviral Therapy Revenue Growth Rate 2013-2018 (Million US$)

Table Asia Pacific Antiretroviral Therapy Sales by Countries (2013-2018) (K Units)

Table Asia Pacific Antiretroviral Therapy Sales Market Share by Countries (2013-2018)

Figure 2017 Asia Pacific Antiretroviral Therapy Sales Market Share by Countries

Table Asia Pacific Antiretroviral Therapy Revenue by Countries (2013-2018) (Million US$)

Table Asia Pacific Antiretroviral Therapy Revenue Market Share by Countries (2013-2018)

Figure 2017 Asia Pacific Antiretroviral Therapy Revenue Market Share by Countries

Figure China Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)

Figure China Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)

Figure Japan Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)

Figure Japan Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)

Figure Korea Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)

Figure Korea Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)

Figure India Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)

Figure India Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)

Figure Australia Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)

Figure Australia Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)

Figure Indonesia Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)

Figure Indonesia Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)

Figure Malaysia Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)

Figure Malaysia Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)

Figure Philippines Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)

Figure Philippines Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)

Figure Thailand Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)

Figure Thailand Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)

Figure Vietnam Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)

Figure Vietnam Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)

Figure Singapore Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)

Figure Singapore Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)

Table Asia Pacific Antiretroviral Therapy Sales by Product (2013-2018) (K Units)

Table Asia Pacific Antiretroviral Therapy Sales Market Share by Product (2013-2018)

Figure 2017 Asia Pacific Antiretroviral Therapy Market Share by Product

Table Asia Pacific Antiretroviral Therapy Sales by End User (2013-2018) (K Units)

Table Asia Pacific Antiretroviral Therapy Sales Market Share by End User (2013-2018)

Figure 2017 Asia Pacific Antiretroviral Therapy Market Share by End User

Figure Central & South America Antiretroviral Therapy Sales Growth Rate 2013-2018 (K Units)

Figure Central & South America Antiretroviral Therapy Revenue Growth Rate 2013-2018 (Million US$)

Table Central & South America Antiretroviral Therapy Sales by Countries (2013-2018) (K Units)

Table Central & South America Antiretroviral Therapy Sales Market Share by Countries (2013-2018)

Figure 2017 Central & South America Antiretroviral Therapy Sales Market Share by Countries

Table Central & South America Antiretroviral Therapy Revenue by Countries (2013-2018) (Million US$)

Table Central & South America Antiretroviral Therapy Revenue Market Share by Countries (2013-2018)

Figure 2017 Central & South America Antiretroviral Therapy Revenue Market Share by Countries

Figure Brazil Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)

Figure Brazil Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)

Figure Argentina Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)

Figure Argentina Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)

Table Central & South America Antiretroviral Therapy Sales by Product (2013-2018) (K Units)

Table Central & South America Antiretroviral Therapy Sales Market Share by Product (2013-2018)

Figure 2017 Central & South America Antiretroviral Therapy Market Share by Product

Table Central & South America Antiretroviral Therapy Sales by End User (2013-2018) (K Units)

Table Central & South America Antiretroviral Therapy Sales Market Share by End User (2013-2018)

Figure 2017 Central & South America Antiretroviral Therapy Market Share by End User

Figure Middle East and Africa Antiretroviral Therapy Sales Growth Rate 2013-2018 (K Units)

Figure Middle East and Africa Antiretroviral Therapy Revenue Growth Rate 2013-2018 (Million US$)

Table Middle East and Africa Antiretroviral Therapy Sales by Countries (2013-2018) (K Units)

Table Middle East and Africa Antiretroviral Therapy Sales Market Share by Countries (2013-2018)

Figure 2017 Middle East and Africa Antiretroviral Therapy Sales Market Share by Countries

Table Middle East and Africa Antiretroviral Therapy Revenue by Countries (2013-2018) (Million US$)

Table Middle East and Africa Antiretroviral Therapy Revenue Market Share by Countries (2013-2018)

Figure 2017 Middle East and Africa Antiretroviral Therapy Revenue Market Share by Countries

Figure GCC Countries Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)

Figure GCC Countries Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)

Figure Turkey Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)

Figure Turkey Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)

Figure Egypt Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)

Figure Egypt Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)

Figure South Africa Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)

Figure South Africa Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)

Table Middle East and Africa Antiretroviral Therapy Sales by Product (2013-2018) (K Units)

Table Middle East and Africa Antiretroviral Therapy Sales Market Share by Product (2013-2018)

Figure 2017 Middle East and Africa Antiretroviral Therapy Market Share by Product

Table Middle East and Africa Antiretroviral Therapy Sales by End User (2013-2018) (K Units)

Table Middle East and Africa Antiretroviral Therapy Sales Market Share by End User (2013-2018)

Figure 2017 Middle East and Africa Antiretroviral Therapy Market Share by End User

Table Gilead Company Details

Table Gilead Antiretroviral Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Gilead Recent Development

Table F. Hoffmann-La Roche Company Details

Table F. Hoffmann-La Roche Antiretroviral Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table F. Hoffmann-La Roche Recent Development

Table ViiV Healthcare Company Details

Table ViiV Healthcare Antiretroviral Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table ViiV Healthcare Recent Development

Table Boehringer Ingelheim Company Details

Table Boehringer Ingelheim Antiretroviral Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Boehringer Ingelheim Recent Development

Table Janssen Pharmaceuticals Company Details

Table Janssen Pharmaceuticals Antiretroviral Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Janssen Pharmaceuticals Recent Development

Table Mylan Company Details

Table Mylan Antiretroviral Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Mylan Recent Development

Table Abbvie Company Details

Table Abbvie Antiretroviral Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Abbvie Recent Development

Table Bionor Pharma Company Details

Table Bionor Pharma Antiretroviral Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Bionor Pharma Recent Development

Table Vertex Pharmaceuticals Company Details

Table Vertex Pharmaceuticals Antiretroviral Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Table Vertex Pharmaceuticals Recent Development

Table Global Antiretroviral Therapy Sales Forecast by Regions 2018-2025 (K Units)

Table Global Antiretroviral Therapy Sales Market Share Forecast by Regions 2018-2025

Table Global Antiretroviral Therapy Revenue Forecast by Regions 2018-2025 (Million US$)

Table Global Antiretroviral Therapy Revenue Market Share Forecast by Regions 2018-2025

Table Global Antiretroviral Therapy Sales Forecast by Product 2018-2025 (K Units)

Table Global Antiretroviral Therapy Sales Market Share Forecast by Product 2018-2025

Table Global Antiretroviral Therapy Revenue Forecast by Product 2018-2025 (Million US$)

Table Global Antiretroviral Therapy Revenue Market Share Forecast by Product 2018-2025

Table Global Antiretroviral Therapy Sales Forecast by End User 2018-2025 (K Units)

Table Global Antiretroviral Therapy Sales Market Share Forecast by End User 2018-2025

Figure North America Antiretroviral Therapy Sales Growth Rate Forecast (2018-2025) (K Units)

Figure North America Antiretroviral Therapy Revenue Growth Rate Forecast (2018-2025) (Million US$)

Figure Europe Antiretroviral Therapy Sales Growth Rate Forecast (2018-2025) (K Units)

Figure Europe Antiretroviral Therapy Revenue Growth Rate Forecast (2018-2025) (Million US$)

Figure Asia Pacific Antiretroviral Therapy Sales Growth Rate Forecast (2018-2025) (K Units)

Figure Asia Pacific Antiretroviral Therapy Revenue Growth Rate Forecast (2018-2025) (Million US$)

Figure Central & South America Antiretroviral Therapy Sales Growth Rate Forecast (2018-2025) (K Units)

Figure Central & South America Antiretroviral Therapy Revenue Growth Rate Forecast (2018-2025) (Million US$)

Figure Middle East and Africa Antiretroviral Therapy Sales Growth Rate Forecast (2018-2025) (K Units)

Figure Middle East and Africa Antiretroviral Therapy Revenue Growth Rate Forecast (2018-2025) (Million US$)

Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016

Figure Forecast of Global Middle-Class Population, 2015 to 2030

Figure Household Disposable Income Gross adjusted, US dollars/capita, 2016

Table Antiretroviral Therapy Value Chain

Table Antiretroviral Therapy Customers List

Table Antiretroviral Therapy Distributors List

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Medical Implants Market By Type (Orthopedic Implants, cardiac implants, Stents, Spinal Implants, Neurostimulators, dental implants, Breast Implants, facial Implants) and By Materials (Metallic, Ceramic, Polymers, Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...

  • Publish Date: August 21, 2016
  • $5370
Ostomy Drainage Bags Market by Type (Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Urostomy Bags, and Continent Ileostomy Bags) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...

  • Publish Date: December 1, 2016
  • $5370